TABLE 2.
Hierarchic Cox regression model evaluating risk factors for mortality in sepsis patientsa
Variable | HR | 95% CI | P |
---|---|---|---|
Step 1, demographic | |||
CRE | 1.70 | 1.25–2.33 | 0.01 |
Age (yr) | 1.01 | 1.01–1.02 | <0.01 |
Step 2, comorbidities | |||
CRE | 1.58 | 1.15–2.17 | <0.01 |
Age (yr) | 1.01 | 1.01–1.02 | <0.01 |
HIV | 2.27 | 1.52–3.39 | <0.01 |
Cancer | 1.32 | 1.06–1.66 | 0.01 |
Cirrhosis | 2.46 | 1.58–3.82 | <0.01 |
Cardiovascular disease | 1.12 | 0.90–1.40 | 0.31 |
Step 3, infection site | |||
CRE | 1.58 | 1.15–2.18 | <0.01 |
Age (yr) | 1.02 | 1.01–1.02 | <0.01 |
HIV | 2.41 | 1.60–3.60 | <0.01 |
Neoplasia | 1.30 | 1.04–1.62 | 0.02 |
Cirrhosis | 2.25 | 1.45–3.51 | <0.01 |
Bacteremia | 1.44 | 1.17–1.77 | <0.01 |
Abdominal infections | 1.40 | 1.05–1.86 | 0.02 |
Urinary tract infections | 0.77 | 0.56–1.05 | 0.10 |
Pulmonary tract infections | 1.20 | 0.95–1.51 | 0.12 |
Step 4, sepsis severity | |||
CRE | 1.20 | 0.88–1.67 | 0.25 |
Age (yr) | 1.01 | 1.01–1.02 | <0.01 |
HIV | 2.06 | 1.37–3.12 | <0.01 |
Neoplasia | 1.02 | 0.96–1.50 | 0.10 |
Cirrhosis | 1.79 | 1.14–2.79 | 0.01 |
Abdominal site infection | 1.14 | 0.88–1.47 | 0.32 |
Bacteremia | 1.11 | 0.90–1.37 | 0.32 |
Septic shock | 3.30 | 2.67–4.08 | <0.01 |
Quick SOFA | 1.22 | 1.08–1.38 | <0.01 |
Step 5, therapy | |||
CRE | 1.21 | 0.88–1.68 | 0.23 |
Age (yr) | 1.01 | 1.01–1.02 | <0.01 |
HIV | 1.93 | 1.28–2.90 | <0.01 |
Cirrhosis | 1.82 | 1.17–2.85 | <0.01 |
Septic shock | 3.52 | 2.86–4.34 | <0.01 |
Quick SOFA | 1.21 | 1.07–1.37 | <0.01 |
Appropriate empirical therapy | 0.73 | 0.57–0.93 | 0.01 |
Abbreviations: HR, hazard ratio; CI, confidence interval; CRE, carbapenem-resistant Enterobacteriaceae.